Skip to main content
Back to News
Introducing GPT-Rosalind for life sciences research
Product
1 min read
US

Introducing GPT-Rosalind for life sciences research

The AMW Read

Updates the player map for Segment 06 by introducing a major frontier lab (OpenAI) into the vertical life sciences research space with a specialized model.
NoveltySignificance
Healthcare & Bio Β· Player Map
OpenAI
OpenAI

Foundation Models / LLMs

View Company Profile

Introducing GPT-Rosalind for life sciences research

OpenAI has introduced GPT-Rosalind, a new AI model designed to accelerate research in drug discovery, genomics, and protein analysis.

Original source: https://openai.com/index/introducing-gpt-rosalind/

#AI#life sciences#drug discovery#OpenAI

How This Connects

Based on Healthcare & Bio Β· Player Map

  1. 4d agoVeeva launches Falcon AI agent platform for autonomous drug developmentVeeva
  2. 6d agoSubtle Medical raises $33M and appoints new CEO to scale AI imaging platformSubtle Medical
  3. 3w agoIsomorphic Labs raises $2.1B led by Thrive Capital in largest AI drug-discovery roundIsomorphic Labs
  4. 1mo agoOpenAI model outperforms doctors in ER diagnoses, achieving 67% accuracy vs 55%OpenAI
  5. 1mo agoIntroducing GPT-Rosalind for life sciences research Β· THIS ARTICLE

Related News

More news from OpenAI

Stay updated with the latest news and announcements from OpenAI.

View all OpenAI news

Discover AI Startups

Explore 2,000+ AI companies with VC-grade analysis, funding data, and investment insights.

Explore Dashboard